Low dose radiation increased the therapeutic efficacy of cyclophosphamide on S(180) sarcoma bearing mice.
We examined whether low dose radiation (LDR) exposure (75 mGy) could increase the therapeutic efficacy of cyclophosphamide (CTX) by comparing the effects of tumor suppression, tumor cell apoptosis, cell cycle and proliferation of bone marrow in vivo. Kunming mice implanted with S(180) sarcoma cells were given 75 mGy whole body gamma-ray radiation exposure and CTX (300 mg/kg) by intraperitoneal injection 36 hours after LDR. Proliferation of bone marrow and tumor cells was analyzed by flow cytometry. Cytochrome c leakage from the tumor was measured by Western-blot. We discovered that tumor growth was significantly reduced in the group exposed to CTX add to LDR. The apoptosis of tumor cells increased significantly after LDR. The tumor cells were arrested in G(1) phase in the groups treated with CTX and CTX + LDR, but cell cycle was more significantly arrested in mice exposed to LDR followed by CTX than in mice exposed only to LDR or CTX chemotherapy. Concentration of bone marrow cells and proliferation index in CTX + LDR mice were higher than those in the untreated mice. LDR or CTX + LDR could induce greater cytochrome c levels and caspase-3 activity in tumors. These results suggest that low dose radiation can enhance the anti-tumor effect of the chemotherapy agent CTX markedly. Furthermore, LDR significantly protects hematopoetic function of the bone marrow, which is of practical significance on adjuvant chemotherapy.
Yu
Hong-Sheng
HS
The Department of Oncology, Affiliated Hospital of Qingdao University, Qingdao, China.
Xue
Hong-Wei
HW
Guo
Chun-Bao
CB
Song
Ai-Qin
AQ
Shen
Fang-Zhen
FZ
Liang
Jun
J
Deng
Chun
C
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology*; D017209:Apoptosis; D001854:Bone Marrow Cells / Q000378:metabolism; D053148:Caspase 3 / Q000378:metabolism; D002453:Cell Cycle; D049109:Cell Proliferation; D002470:Cell Survival; D003520:Cyclophosphamide / Q000494:pharmacology*; D045304:Cytochromes c / Q000378:metabolism; D005434:Flow Cytometry; D006412:Hematopoietic Stem Cells / Q000166:cytology; D051379:Mice; D009368:Neoplasm Transplantation; D012509:Sarcoma / Q000188:drug therapy* / Q000532:radiotherapy*
D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide; D045304:Cytochromes c; D053148:Caspase 3